$108.10
Value $8.7B
HNGE and INTC stock compared: price, dividend, valuation and results, from SEC filings.
$108.10
Value $8.7B
$55.72
Value $296B
Hinge Health (HNGE) has a market value of $8.7B and Intel (INTC) $296B. Over the last year, with dividends, HNGE moved +180.4% and INTC +57.5%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
HNGE$8.7B
INTC$296B
INTC is 34 times HNGE
Revenue, 12 months
HNGE$801M
INTC$59.9B
INTC is 75 times HNGE
Net income, 12 months
HNGE$168M
INTC-$12.0B
Operating margin
HNGE18.7%
INTC2.9%
15.8 points apart
ROIC
HNGE51.9%
INTC0.9%
51.0 points apart
P/E
HNGE52.5
INTC–
Dividend yield
HNGE0.0%
INTC0.0%
About the same
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
HNGE+180.4%
INTC+57.5%
| Period | HNGEWith dividends | INTCWith dividends |
|---|---|---|
| 1 year since November 17, 2025 | +180.4%Price +180.4% | +57.5%Price +57.5% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
HNGEHinge HealthINTCIntel
| Price | $108.10 | $55.72 |
|---|---|---|
| Market value | $8.7B | $296B |
| Enterprise value (EV) | $8.4B | $292B |
| P/E | 52.5 | – |
| P/E, 5-year median | – | – |
| P/B | 29.2 | 2.6 |
| EV/EBIT | 56.3 | 165.9 |
| Free cash flow yield | 3.7% | 1.3% |
| Revenue, 12 months | $801M | $59.9B |
|---|---|---|
| Net income, 12 months | $168M | -$12.0B |
| Free cash flow, 12 months | $322M | $3.8B |
| Earnings per share, 12 months | $2.06 | -$2.42 |
| Revenue growth, year on year | 50.6% | -0.5% |
| Revenue growth a year, past | +41.7%over 2 years | -7.5%over 5 years |
| EPS growth a year, past | – | – |
| Gross margin | 85.7% | 39.9% |
|---|---|---|
| Operating margin | 18.7% | 2.9% |
| Net margin | 21.0% | -20.1% |
| ROIC | 51.9% | 0.9% |
| ROE | 73.7% | -11.3% |
| Cash | $295M | $54.0B |
|---|---|---|
| Total debt | $34M | $50.1B |
| Net debt / EBITDA | -1.9 | -0.3 |
| Interest cover | – | 1.5× |
| Dividend yield | – | – |
|---|---|---|
| Dividend per share, 12 months | – | – |
| Dividend growth a year, past | – | – |
| Buyback yield | 0.7% | – |
| Shareholder yield | 0.7% | – |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, Intel ($296B) is about 33.9 times Hinge Health ($8.7B), at today's prices.
Since November 17, 2025, HNGE's price moved +180.4% and INTC's +57.5%. With dividends: HNGE +180.4% (+180.4% a year), INTC +57.5% (+57.5% a year). Past returns do not predict future ones.
Neither paid a dividend over the last twelve months: Hinge Health and Intel return money to shareholders, if they do, in other ways, such as buybacks.
Over the last twelve months, the net margin was 21.0% for Hinge Health and -20.1% for Intel, and the operating margin 18.7% and 2.9%. Revenue was $801M and $59.9B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.